Menu Back to Advertising-and-Promotion-Regulatory-Affairs-Conference

Overview

Primer
Conference: 8-9

DIA’s Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space.

This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for effective patient engagement, and discusses the trends in advertising for medical products. You will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory practitioners, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.

Social distancing measures may be in place at the time of the event. Therefore, we encourage you to register and make your housing arrangements early due to potential limited capacity. If the capacity limit is reached, we will only be able to offer the virtual option. Don’t miss out on your chance to meet live again with your friends and colleagues!

Who should attend?

Professionals involved in:

  • Regulatory Affairs
  • Marketing
  • Communications
  • Compliance
  • Medical Information and Affairs
  • Legal
  • Patient Engagement

Program Committee

  • Micheline  Awad, MBA
    Micheline Awad, MBA Director Regulatory Affairs, Advertising and Promotion
    Neurocrine Biosciences, Inc., United States
  • Sheetal  Patel, PharmD
    Sheetal Patel, PharmD Head, Regulatory Advertising and Promotion
    Johnson & Johnson International, United States
  • Fadwa  Almanakly, PharmD
    Fadwa Almanakly, PharmD Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas
    Bayer Pharmaceuticals, United States
  • Heather  Banuelos, JD
    Heather Banuelos, JD Counsel
    King & Spalding LLP, United States
  • Kimberly  Belsky, MS
    Kimberly Belsky, MS Executive Director Reg Policy & Intelligence and AdPromo Regulatory Affairs
    Mallinckrodt Pharmaceuticals, United States
  • Carla  Brooks, MSc, RAC
    Carla Brooks, MSc, RAC Senior Director, Regulatory Affairs, Advertising and Promotion
    Blueprint Medicines Corporation, United States
  • Robert  Dean
    Robert Dean Director, Advertising and Promotion
    Merck, United States
  • Virginia  Foley
    Virginia Foley Head of Marketing and Strategic Business Development
    Opus Regulatory Inc, United States
  • Catherine  Gray, PharmD
    Catherine Gray, PharmD Director (Acting), Office of Prescription Drug Promotion, OMP, CDER
    FDA, United States
  • Joanne  Hawana, JD, MS
    Joanne Hawana, JD, MS Member
    Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States
  • Georgina  Lee, PharmD
    Georgina Lee, PharmD Senior Director, Regulatory Affairs Advertising & Promotion and Labeling
    Acceleron Pharma, United States
  • Dale  Cooke, JD, MA
    Dale Cooke, JD, MA President
    PhillyCooke Consulting , United States
  • Mark  Gaydos
    Mark Gaydos Vice President & Head, Global Advertising, Promotion & Labeling
    Sanofi, United States
  • Wayne  Pines
    Wayne Pines President, Health Care
    APCO Worldwide Inc., United States
  • Lucy  Rose, MBA
    Lucy Rose, MBA President
    Lucy Rose and Associates, LLC, United States
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download